Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

Doctors report insurance cuts are forcing many U.S. patients on Wegovy and Zepbound to pay high out-of-pocket costs.

Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

Medicare covers weight loss drugs including Ozempic under specific conditions when the drug also has potential use cases beyond weight loss.

Health insurance company Cigna (NYSE:CI) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up ...